The lab was awarded a new grant through the Cornell Technology Acceleration and Maturation (CTAM) Fund. The grant will support development of our recombinant lubricin therapeutics along a path towards commercialization.
top of page
Search
Recent Posts
See AllCongrats to Steven on passing the Admission to Candidacy exam! Steven's continued work seeks to understand on a molecular level what...
bottom of page
Comments